{"DataElement":{"publicId":"6729501","version":"1","preferredName":"Response Evaluation Criteria In Lymphoma (RECIL) 2017 Assessment Code","preferredDefinition":"Code that represents the assessment of response to treatment for lymphoma using the Response Evaluation Criteria in Lymphoma (RECIL) 2017.","longName":"RECIL2017_ASMT_CD","context":"CCR","contextVersion":"1","DataElementConcept":{"publicId":"6729403","version":"1","preferredName":"Response Evaluation Criteria In Lymphoma 2017 Assessment","preferredDefinition":"The 2017 update to an international-consensus set of response criteria for lymphoma first established in 1999. These guidelines were refined in 2007 to incorporate assessment of tumor metabolism by [18F]2-fluoro-2-deoxy-D-glucose positron emission tomography (FDG-PET) and further refined in 2017 to incorporate a scoring system to enhance the reproducibility of the interpretation and reporting of FDG-PET results, and to update the recommended procedures for staging evaluation._The final result of a determination of the value, significance, or extent of.","longName":"6729401v1.0:2465182v1.0","context":"CCR","contextVersion":"1","ObjectClass":{"publicId":"6729401","version":"1","preferredName":"Response Evaluation Criteria In Lymphoma 2017","preferredDefinition":"The 2017 update to an international-consensus set of response criteria for lymphoma first established in 1999. These guidelines were refined in 2007 to incorporate assessment of tumor metabolism by [18F]2-fluoro-2-deoxy-D-glucose positron emission tomography (FDG-PET) and further refined in 2017 to incorporate a scoring system to enhance the reproducibility of the interpretation and reporting of FDG-PET results, and to update the recommended procedures for staging evaluation.","longName":"C159617","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Response Evaluation Criteria In Lymphoma 2017","conceptCode":"C159617","definition":"The 2017 update to an international-consensus set of response criteria for lymphoma first established in 1999. These guidelines were refined in 2007 to incorporate assessment of tumor metabolism by [18F]2-fluoro-2-deoxy-D-glucose positron emission tomography (FDG-PET) and further refined in 2017 to incorporate a scoring system to enhance the reproducibility of the interpretation and reporting of FDG-PET results, and to update the recommended procedures for staging evaluation.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"874B6901-564E-7436-E053-F662850A2C0F","latestVersionIndicator":"Yes","beginDate":"2019-04-24","endDate":null,"createdBy":"COOPERM","dateCreated":"2019-04-24","modifiedBy":"ONEDATA","dateModified":"2019-04-24","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"2465182","version":"1","preferredName":"Assessed","preferredDefinition":"Having determined the value, significance, or extent of.","longName":"C25217","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Assessment","conceptCode":"C25217","definition":"The final result of a determination of the value, significance, or extent of.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"0F836E72-26FF-3EB2-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-03-22","endDate":null,"createdBy":"ALAIS","dateCreated":"2006-03-22","modifiedBy":"ONEDATA","dateModified":"2006-03-22","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008550","version":"1","preferredName":"Disease Response","preferredDefinition":"the response criteria (includes RECIST and others) and associated documentation of disease.","longName":"DZ_RESP","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B22C0651-216B-5273-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-19","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-19","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"874B6901-565C-7436-E053-F662850A2C0F","latestVersionIndicator":"Yes","beginDate":"2019-04-24","endDate":null,"createdBy":"COOPERM","dateCreated":"2019-04-24","modifiedBy":"COOPERM","dateModified":"2019-05-07","changeDescription":"Created for NCI-INC0370865 19C0076 qns curation. 4.17.19 mc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"6729405","version":"1","preferredName":"RECIL 2017 Code","preferredDefinition":"A symbol or combination of symbols which is assigned to the members of a collection.","longName":"RECIL2017_CD","context":"CCR","contextVersion":"1","type":"Enumerated","dataType":"CHARACTER","minLength":null,"maxLength":"2","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"MR","valueDescription":"RECIL MR","ValueMeaning":{"publicId":"6729408","version":"1","preferredName":"RECIL MR","longName":"6729408","preferredDefinition":"Greater than or equal to 10 percent decrease in the sum of longest diameters of target lesions but not a partial response.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"RECIL MR","conceptCode":"C159620","definition":"Greater than or equal to 10 percent decrease in the sum of longest diameters of target lesions but not a partial response.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"87488E7A-F323-5A65-E053-F662850A2E1E","latestVersionIndicator":"Yes","beginDate":"2019-04-24","endDate":null,"createdBy":"COOPERM","dateCreated":"2019-04-24","modifiedBy":"ONEDATA","dateModified":"2019-04-24","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"87488E7A-F33C-5A65-E053-F662850A2E1E","beginDate":"2019-04-24","endDate":null,"createdBy":"COOPERM","dateCreated":"2019-04-24","modifiedBy":"ONEDATA","dateModified":"2019-04-24","deletedIndicator":"No"},{"value":"PD","valueDescription":"RECIL PD","ValueMeaning":{"publicId":"6729406","version":"1","preferredName":"RECIL PD","longName":"6729406","preferredDefinition":"Greater than 20 percent increase in the sum of longest diameters of target lesions; For small lymph nodes measuring less than15 mm post therapy, a minimum absolute increase of 5 mm and the long diameter should exceed 15 mm; Appearance of a new lesion.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"RECIL PD","conceptCode":"C159622","definition":"Greater than 20 percent increase in the sum of longest diameters of target lesions; For small lymph nodes measuring less than15 mm post therapy, a minimum absolute increase of 5 mm and the long diameter should exceed 15 mm; Appearance of a new lesion.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"87488E7A-F2D9-5A65-E053-F662850A2E1E","latestVersionIndicator":"Yes","beginDate":"2019-04-24","endDate":null,"createdBy":"COOPERM","dateCreated":"2019-04-24","modifiedBy":"ONEDATA","dateModified":"2019-04-24","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"87488E7A-F2F2-5A65-E053-F662850A2E1E","beginDate":"2019-04-24","endDate":null,"createdBy":"COOPERM","dateCreated":"2019-04-24","modifiedBy":"ONEDATA","dateModified":"2019-04-24","deletedIndicator":"No"},{"value":"SD","valueDescription":"RECIL SD","ValueMeaning":{"publicId":"6729407","version":"1","preferredName":"RECIL SD","longName":"6729407","preferredDefinition":"Less Than 10 percent decrease or less than or equal to 20 percent increase in the sum of longest diameters of target lesions.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"RECIL SD","conceptCode":"C159621","definition":"Less Than 10 percent decrease or less than or equal to 20 percent increase in the sum of longest diameters of target lesions.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"87488E7A-F2FE-5A65-E053-F662850A2E1E","latestVersionIndicator":"Yes","beginDate":"2019-04-24","endDate":null,"createdBy":"COOPERM","dateCreated":"2019-04-24","modifiedBy":"COOPERM","dateModified":"2019-04-24","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"87488E7A-F317-5A65-E053-F662850A2E1E","beginDate":"2019-04-24","endDate":null,"createdBy":"COOPERM","dateCreated":"2019-04-24","modifiedBy":"ONEDATA","dateModified":"2019-04-24","deletedIndicator":"No"},{"value":"PR","valueDescription":"RECIL PR","ValueMeaning":{"publicId":"6729409","version":"1","preferredName":"RECIL PR","longName":"6729409","preferredDefinition":"Greater than or equal to 30 percent decrease in the sum of longest diameters of target lesions but not a complete response.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"RECIL PR","conceptCode":"C159619","definition":"Greater than or equal to 30 percent decrease in the sum of longest diameters of target lesions but not a complete response.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"87488E7A-F348-5A65-E053-F662850A2E1E","latestVersionIndicator":"Yes","beginDate":"2019-04-24","endDate":null,"createdBy":"COOPERM","dateCreated":"2019-04-24","modifiedBy":"ONEDATA","dateModified":"2019-04-24","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"87488E7A-F361-5A65-E053-F662850A2E1E","beginDate":"2019-04-24","endDate":null,"createdBy":"COOPERM","dateCreated":"2019-04-24","modifiedBy":"ONEDATA","dateModified":"2019-04-24","deletedIndicator":"No"},{"value":"CR","valueDescription":"RECIL CR","ValueMeaning":{"publicId":"6729410","version":"1","preferredName":"RECIL CR","longName":"6729410","preferredDefinition":"Complete disappearance of all target lesions and all nodes with long axis less than10mm; greater than or equal to 30 percent decrease in the sum of longest diameters of target lesions (partial response) with normalization of FDG-PE.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"RECIL CR","conceptCode":"C159618","definition":"Complete disappearance of all target lesions and all nodes with long axis less than10mm; greater than or equal to 30 percent decrease in the sum of longest diameters of target lesions (partial response) with normalization of FDG-PE.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"87488E7A-F36D-5A65-E053-F662850A2E1E","latestVersionIndicator":"Yes","beginDate":"2019-04-24","endDate":null,"createdBy":"COOPERM","dateCreated":"2019-04-24","modifiedBy":"ONEDATA","dateModified":"2019-04-24","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"87488E7A-F386-5A65-E053-F662850A2E1E","beginDate":"2019-04-24","endDate":null,"createdBy":"COOPERM","dateCreated":"2019-04-24","modifiedBy":"ONEDATA","dateModified":"2019-04-24","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2008550","version":"1","preferredName":"Disease Response","preferredDefinition":"the response criteria (includes RECIST and others) and associated documentation of disease.","longName":"DZ_RESP","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B22C0651-216B-5273-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-19","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-19","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"2261841","version":"1","preferredName":"Code","preferredDefinition":"A system of numbered categories for representation of data.","longName":"C25162","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Code","conceptCode":"C25162","definition":"A symbol or combination of symbols which is assigned to the members of a collection.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Standard","id":"FBB87F7A-6427-1AFC-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-07-13","endDate":null,"createdBy":"MAESKEB","dateCreated":"2005-07-13","modifiedBy":"SBR","dateModified":"2005-09-08","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"87488E7A-F2C1-5A65-E053-F662850A2E1E","latestVersionIndicator":"Yes","beginDate":"2019-04-24","endDate":null,"createdBy":"COOPERM","dateCreated":"2019-04-24","modifiedBy":"COOPERM","dateModified":"2019-05-07","changeDescription":"Created for NCI-INC0370865 19C0076 qns curation request. 4.17.19 mc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"2008601","version":"1","longName":"C3D Domain","context":"CCR","ClassificationSchemeItems":[{"publicId":"2811685","version":"1","longName":"CCR","context":"CCR"}]},{"publicId":"2182125","version":"1","longName":"CCR Implementation","context":"CCR","ClassificationSchemeItems":[{"publicId":"2811673","version":"1","longName":"C3D","context":"CCR"}]}],"AlternateNames":[],"ReferenceDocuments":[{"name":"RECIL 2017 criteria","type":"Preferred Question Text","description":"RECIL 2017 criteria","url":null,"context":"CCR"}],"origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"87491500-12D1-575E-E053-F662850A3604","latestVersionIndicator":"Yes","beginDate":"2019-04-24","endDate":null,"createdBy":"COOPERM","dateCreated":"2019-04-24","modifiedBy":"COOPERM","dateModified":"2019-05-07","changeDescription":"Created for NCI-INC0370865 19C0076 qns curation request. 4.17.19 mc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}